ID   PPR3B_HUMAN             Reviewed;         285 AA.
AC   Q86XI6; B3KTV3; Q9H812;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   10-MAY-2017, entry version 110.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 3B;
DE   AltName: Full=Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 4;
DE            Short=PP1 subunit R4;
DE   AltName: Full=Protein phosphatase 1 subunit GL;
DE            Short=PTG;
GN   Name=PPP1R3B; Synonyms=PPP1R4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver, and Retinoblastoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11872655; DOI=10.2337/diabetes.51.3.591;
RA   Munro S., Cuthbertson D.J., Cunningham J., Sales M., Cohen P.T.W.;
RT   "Human skeletal muscle expresses a glycogen-targeting subunit of PP1
RT   that is identical to the insulin-sensitive glycogen-targeting subunit
RT   G(L) of liver.";
RL   Diabetes 51:591-598(2002).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=17555403; DOI=10.1042/BJ20061572;
RA   Montori-Grau M., Guitart M., Lerin C., Andreu A.L., Newgard C.B.,
RA   Garcia-Martinez C., Gomez-Foix A.M.;
RT   "Expression and glycogenic effect of glycogen-targeting protein
RT   phosphatase 1 regulatory subunit GL in cultured human muscle.";
RL   Biochem. J. 405:107-113(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   STRUCTURE BY NMR OF 105-253.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CBM21 domain from human protein phosphatase
RT   1, regulatory (inhibitor) subunit 3B.";
RL   Submitted (AUG-2007) to the PDB data bank.
CC   -!- FUNCTION: Acts as a glycogen-targeting subunit for phosphatase
CC       PP1. Facilitates interaction of the PP1 with enzymes of the
CC       glycogen metabolism and regulates its activity. Suppresses the
CC       rate at which PP1 dephosphorylates (inactivates) glycogen
CC       phosphorylase and enhances the rate at which it activates glycogen
CC       synthase and therefore limits glycogen breakdown. Its activity is
CC       inhibited by PYGL, resulting in inhibition of the glycogen
CC       synthase and glycogen phosphorylase phosphatase activities of PP1.
CC       Dramatically increases basal and insulin-stimulated glycogen
CC       synthesis upon overexpression in hepatocytes (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with glycogen, PPP1CC catalytic subunit of PP1
CC       and PYGL. Associates with glycogen particles. Forms complexes with
CC       debranching enzyme, glycogen phosphorylase, glycogen synthase and
CC       phosphorylase kinase which is necessary for its regulation of PP1
CC       activity (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the liver and, at lower
CC       levels, in skeletal muscle, including in vastus lateralis,
CC       gastrocnemius and soleus (at protein level). Highest mRNA levels
CC       are observed in skeletal muscle, and only moderate levels in liver
CC       and heart. Weak expression in placenta and lung.
CC       {ECO:0000269|PubMed:11872655, ECO:0000269|PubMed:17555403}.
CC   -!- DOMAIN: The N-terminal region is required for binding to PP1, the
CC       central region is required for binding to glycogen and the C-
CC       terminal region is required for binding to PYGL. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK024067; BAB14811.1; -; mRNA.
DR   EMBL; AK096119; BAG53215.1; -; mRNA.
DR   EMBL; CH471157; EAW65572.1; -; Genomic_DNA.
DR   EMBL; BC043388; AAH43388.1; -; mRNA.
DR   CCDS; CCDS5973.1; -.
DR   RefSeq; NP_001188258.1; NM_001201329.1.
DR   RefSeq; NP_078883.2; NM_024607.3.
DR   RefSeq; XP_006716316.1; XM_006716253.3.
DR   RefSeq; XP_016869324.1; XM_017013835.1.
DR   UniGene; Hs.458513; -.
DR   PDB; 2EEF; NMR; -; A=105-253.
DR   PDBsum; 2EEF; -.
DR   ProteinModelPortal; Q86XI6; -.
DR   SMR; Q86XI6; -.
DR   BioGrid; 122786; 9.
DR   IntAct; Q86XI6; 6.
DR   MINT; MINT-1180809; -.
DR   STRING; 9606.ENSP00000308318; -.
DR   CAZy; CBM21; Carbohydrate-Binding Module Family 21.
DR   iPTMnet; Q86XI6; -.
DR   PhosphoSitePlus; Q86XI6; -.
DR   BioMuta; PPP1R3B; -.
DR   DMDM; 74727837; -.
DR   EPD; Q86XI6; -.
DR   MaxQB; Q86XI6; -.
DR   PaxDb; Q86XI6; -.
DR   PeptideAtlas; Q86XI6; -.
DR   PRIDE; Q86XI6; -.
DR   DNASU; 79660; -.
DR   Ensembl; ENST00000310455; ENSP00000308318; ENSG00000173281.
DR   Ensembl; ENST00000519699; ENSP00000428642; ENSG00000173281.
DR   GeneID; 79660; -.
DR   KEGG; hsa:79660; -.
DR   UCSC; uc003wsn.5; human.
DR   CTD; 79660; -.
DR   DisGeNET; 79660; -.
DR   GeneCards; PPP1R3B; -.
DR   H-InvDB; HIX0007298; -.
DR   HGNC; HGNC:14942; PPP1R3B.
DR   HPA; HPA028731; -.
DR   MIM; 610541; gene.
DR   neXtProt; NX_Q86XI6; -.
DR   OpenTargets; ENSG00000173281; -.
DR   PharmGKB; PA33652; -.
DR   eggNOG; KOG3986; Eukaryota.
DR   eggNOG; ENOG4111FT1; LUCA.
DR   GeneTree; ENSGT00530000062978; -.
DR   HOGENOM; HOG000026799; -.
DR   HOVERGEN; HBG052744; -.
DR   InParanoid; Q86XI6; -.
DR   KO; K07189; -.
DR   OMA; MVKVFSE; -.
DR   OrthoDB; EOG091G0GB5; -.
DR   PhylomeDB; Q86XI6; -.
DR   TreeFam; TF105537; -.
DR   ChiTaRS; PPP1R3B; human.
DR   EvolutionaryTrace; Q86XI6; -.
DR   GenomeRNAi; 79660; -.
DR   PRO; PR:Q86XI6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000173281; -.
DR   CleanEx; HS_PPP1R3B; -.
DR   Genevisible; Q86XI6; HS.
DR   GO; GO:0042587; C:glycogen granule; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IEA:Ensembl.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IEA:Ensembl.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0005981; P:regulation of glycogen catabolic process; IDA:MGI.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR005036; CBM21_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR017434; Pase-1_reg-su_3B/C/D_met.
DR   InterPro; IPR030682; PP1_3B.
DR   PANTHER; PTHR12307:SF32; PTHR12307:SF32; 1.
DR   Pfam; PF03370; CBM_21; 1.
DR   PIRSF; PIRSF038207; PP1_GT_animal; 1.
DR   PROSITE; PS51159; CBM21; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Complete proteome;
KW   Glycogen metabolism; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    285       Protein phosphatase 1 regulatory subunit
FT                                3B.
FT                                /FTId=PRO_0000324543.
FT   DOMAIN      125    233       CBM21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00491}.
FT   MOTIF        62     65       PP1-binding motif.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C767}.
FT   VARIANT      48     48       G -> E (in dbSNP:rs3748140).
FT                                /FTId=VAR_039814.
FT   CONFLICT    149    149       V -> A (in Ref. 1; BAB14811).
FT                                {ECO:0000305}.
FT   STRAND      110    114       {ECO:0000244|PDB:2EEF}.
FT   HELIX       121    130       {ECO:0000244|PDB:2EEF}.
FT   STRAND      131    141       {ECO:0000244|PDB:2EEF}.
FT   STRAND      144    151       {ECO:0000244|PDB:2EEF}.
FT   STRAND      154    156       {ECO:0000244|PDB:2EEF}.
FT   STRAND      159    167       {ECO:0000244|PDB:2EEF}.
FT   STRAND      170    176       {ECO:0000244|PDB:2EEF}.
FT   STRAND      183    185       {ECO:0000244|PDB:2EEF}.
FT   STRAND      187    189       {ECO:0000244|PDB:2EEF}.
FT   STRAND      191    194       {ECO:0000244|PDB:2EEF}.
FT   STRAND      209    216       {ECO:0000244|PDB:2EEF}.
FT   STRAND      219    224       {ECO:0000244|PDB:2EEF}.
FT   HELIX       225    227       {ECO:0000244|PDB:2EEF}.
FT   STRAND      232    234       {ECO:0000244|PDB:2EEF}.
FT   TURN        235    237       {ECO:0000244|PDB:2EEF}.
SQ   SEQUENCE   285 AA;  32695 MW;  77178FE100947989 CRC64;
     MMAVDIEYRY NCMAPSLRQE RFAFKISPKP SKPLRPCIQL SSKNEASGMV APAVQEKKVK
     KRVSFADNQG LALTMVKVFS EFDDPLDMPF NITELLDNIV SLTTAESESF VLDFSQPSAD
     YLDFRNRLQA DHVCLENCVL KDKAIAGTVK VQNLAFEKTV KIRMTFDTWK SYTDFPCQYV
     KDTYAGSDRD TFSFDISLPE KIQSYERMEF AVYYECNGQT YWDSNRGKNY RIIRAELKST
     QGMTKPHSGP DLGISFDQFG SPRCSYGLFP EWPSYLGYEK LGPYY
//
